SCHEMBL30730185

SCHEMBL30730185

COC(=O)c1cccc(Cn2cc(C(=O)O)cn2)c1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.62
▸ TDP1 Q9NUW8 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ CD74 P04233 1/20 0.58
▸ MIF P14174 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.54
▸ HTT P42858 1/20 0.52
▸ LOXL2 Q9Y4K0 1/20 0.51
▸ SLC7A5 Q01650 1/20 0.51
▸ TAS2R8 Q9NYW2 2/20 0.50
▸ CYP4F2 P78329 2/20 0.50
▸ CYP4A11 Q02928 2/20 0.50
▸ ABHD6 Q9BV23 1/20 0.49
▸ HPGD P15428 1/20 0.48
▸ MAPK10 P53779 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ALK Q9UM73 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19116684 0.86 CD74 (0.57) POLBTDP1L3MBTL1CD74MIF
SCHEMBL19086984 0.86 CD74 (0.57) POLBTDP1L3MBTL1CD74MIF
SCHEMBL30730090 0.86 CD74 (0.54) POLBTDP1L3MBTL1CD74MIF
SCHEMBL13555495 0.85 L3MBTL1 (0.58) POLBTDP1L3MBTL1CD74MIF
SCHEMBL6032891 0.85 CD74 (0.56) POLBTDP1L3MBTL1CD74MIF
SCHEMBL2715134 0.85 HPGD (0.64) POLBTDP1L3MBTL1CD74MIF
SCHEMBL4785951 0.84 HSD17B10 (0.59) POLBTDP1L3MBTL1KDM4ELOXL2
SCHEMBL4017203 0.84 L3MBTL1 (0.60) POLBTDP1L3MBTL1KDM4EHTT
SCHEMBL3765456 0.84 KLKB1 (0.53) POLBTDP1L3MBTL1KDM4EALDH1A1
SCHEMBL19086978 0.84 KDM4E (0.58) POLBTDP1L3MBTL1CD74MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback